Wordt geladen...
A Case of Immune Checkpoint Inhibitor Refractory Colitis Treated with Mycophenolate and High-dose Steroids
Immune checkpoint inhibitors (ICPI) are a class of chemotherapy agents that have emerged as a front-line treatment option for multiple cancers. Nivolumab is an ICPI agent commonly used to treat metastatic melanoma. Although promising, the adverse reaction of this class is broad and per reports, the...
Bewaard in:
| Gepubliceerd in: | Cureus |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cureus
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6957235/ https://ncbi.nlm.nih.gov/pubmed/31938669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.6392 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|